Log in to save to my catalogue

The Role of Lipid Biomarkers in Major Depression

The Role of Lipid Biomarkers in Major Depression

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5371911

The Role of Lipid Biomarkers in Major Depression

About this item

Full title

The Role of Lipid Biomarkers in Major Depression

Publisher

Switzerland: MDPI AG

Journal title

Healthcare (Basel), 2017-02, Vol.5 (1), p.5

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

In the UK, the lifetime-documented prevalence of major depressive disorder (MDD) is currently 10%. Despite its increasing prevalence and devastating impact on quality of life, the pathophysiological mechanisms underpinning MDD remain to be fully elucidated. Current theories of neurobiological components remain incomplete and protein-centric, render...

Alternative Titles

Full title

The Role of Lipid Biomarkers in Major Depression

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5371911

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5371911

Other Identifiers

ISSN

2227-9032

E-ISSN

2227-9032

DOI

10.3390/healthcare5010005

How to access this item